Repligen Corp. (RGEN)
135.68
-1.54
(-1.12%)
USD |
NASDAQ |
Feb 20, 16:00
135.72
+0.04
(+0.03%)
After-Hours: 20:00
Repligen Price : 135.68 for Feb. 20, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Abbott Laboratories | 112.21 |
| Accuray, Inc. | 0.5353 |
| Alphatec Holdings, Inc. | 13.01 |
| Boston Scientific Corp. | 74.58 |
| Plus Therapeutics, Inc. | 0.275 |
Price Related Metrics
| PE Ratio | 5258.91 |
| PS Ratio | 10.81 |
| Price to Book Value | 3.666 |
| Price to Free Cash Flow | 73.97 |
| Earnings Yield | 0.02% |
| Market Cap | 7.638B |
| Operating PE Ratio | 163.84 |
| Normalized PE Ratio | 225.94 |